Chisembele, Maureen

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A. M., Gafos, M., Jentsch, U., Pool, R., Chisembele, M., Kapiga, S., et al. (2010) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 335

Comprehensive pregnancy monitoring with a network of wireless, soft, and flexible sensors in high- and low-resource health settings

Ryu, D., Kim, D. H., Price, J. T., Lee, J. Y., Chung, H. U., Allen, E., Walter, J. R., Jeong, H., Cao, J., Kulikova, E., et al. (2021) · Proceedings of the National Academy of Sciences

Non-Invasive Vital Sign MonitoringAdvanced Sensor and Energy Harvesting Materials

Cited by 105

Wireless skin sensors for physiological monitoring of infants in low-income and middle-income countries

Xu, S., Rwei, A. Y., Vwalika, B., Chisembele, M. P., Stringer, J. S. A., Ginsburg, A. S., & Rogers, J. A. (2021) · The Lancet Digital Health

Non-Invasive Vital Sign MonitoringAdvanced Sensor and Energy Harvesting Materials

Cited by 57